Although a recent meta-analysis demonstrated that treatment with a SGLT2i was associated with significant improvements in plasma NT-proBNP concentrations in patients with T2DM, irrespective of the presence of HF, the LVEF level was improved only in HFrEF [28]. Here, NPPB is linked to type 2 diabetes mellitus.